Feda Azab
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Hematology top 1%
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 43
- Multiple Myeloma Research and Treatments 38
-
- PI3K/AKT/mTOR signaling in cancer 9
- Co-authors
- Abdel Kareem Azab (65 shared papers)Barbara Muz (22 shared papers)Pilar de la Puente (20 shared papers)Irene M. Ghobrial (52 shared papers)Aldo M. Roccaro (46 shared papers)Antonio Sacco (47 shared papers)Patricia Maiso (28 shared papers)Hai T. Ngo (41 shared papers)
- Journals
- Blood (43 papers)Clinical Cancer Research (7 papers)Cancer Research (2 papers)Molecular Cancer Research (2 papers)British Journal of Haematology (2 papers)
- Partner nations
- United StatesItalyBelgium
In The Last Decade
Feda Azab
76 papers receiving 4.4k citations
Feda Azab's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 1.5k
- Hematology 945
- Genetics 634
- Oncology 971
- Molecular Biology 2.3k
Countries citing papers authored by Feda Azab
This map shows the geographic impact of Feda Azab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feda Azab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feda Azab more than expected).
Fields of papers citing papers by Feda Azab
This network shows the impact of papers produced by Feda Azab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feda Azab. The network helps show where Feda Azab may publish in the future.
Co-authors
The 25 scholars most cited alongside Feda Azab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy Hit paper breakdown → | 2015 | 1559 |
| 2 | BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression Hit paper breakdown → | 2013 | 650 |
| 3 | 2009 | 245 | |
| 4 | 2012 | 239 | |
| 5 | 2012 | 120 | |
| 6 | 2015 | 105 | |
| 7 | 2011 | 98 | |
| 8 | 2010 | 96 | |
| 9 | 2008 | 93 | |
| 10 | 2010 | 91 | |
| 11 | 2013 | 90 | |
| 12 | 2009 | 89 | |
| 13 | 2008 | 88 | |
| 14 | 2009 | 81 | |
| 15 | 2011 | 67 | |
| 16 | 2008 | 65 | |
| 17 | 2010 | 65 | |
| 18 | 2014 | 48 | |
| 19 | 2014 | 41 | |
| 20 | 2013 | 37 |
About Feda Azab
Feda Azab is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Pathology and Forensic Medicine, having authored 77 papers that have together received 4.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (38 papers), Chronic Lymphocytic Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (10 papers), Chemokine receptors and signaling (10 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Cell Adhesion Molecules Research (6 papers), MicroRNA in disease regulation (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Cancer Research (1.5k citations), Hematology (945 citations), Genetics (634 citations), Oncology (971 citations) and Molecular Biology (2.3k citations). Feda Azab has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Abdel Kareem Azab, Barbara Muz, Pilar de la Puente, Irene M. Ghobrial, Aldo M. Roccaro, Antonio Sacco, Patricia Maiso, Hai T. Ngo, Kenneth C. Anderson and Judith Runnels. Their work appears in journals such as Blood, Clinical Cancer Research, Cancer Research, Molecular Cancer Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.